[go: up one dir, main page]

WO2020240258A1 - Dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques - Google Patents

Dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques Download PDF

Info

Publication number
WO2020240258A1
WO2020240258A1 PCT/IB2019/054448 IB2019054448W WO2020240258A1 WO 2020240258 A1 WO2020240258 A1 WO 2020240258A1 IB 2019054448 W IB2019054448 W IB 2019054448W WO 2020240258 A1 WO2020240258 A1 WO 2020240258A1
Authority
WO
WIPO (PCT)
Prior art keywords
capillary
previous
optical module
electromagnetic radiation
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2019/054448
Other languages
English (en)
Inventor
Viktor TOMAŠOV
Oleg ADAMCHUK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP19742649.7A priority Critical patent/EP3977097A1/fr
Priority to PCT/IB2019/054448 priority patent/WO2020240258A1/fr
Publication of WO2020240258A1 publication Critical patent/WO2020240258A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/8483—Investigating reagent band
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J1/00—Photometry, e.g. photographic exposure meter
    • G01J1/42—Photometry, e.g. photographic exposure meter using electric radiation detectors
    • G01J1/44—Electric circuits
    • G01J2001/4413—Type
    • G01J2001/442—Single-photon detection or photon counting
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J1/00—Photometry, e.g. photographic exposure meter
    • G01J1/42—Photometry, e.g. photographic exposure meter using electric radiation detectors
    • G01J1/44—Electric circuits
    • G01J2001/444—Compensating; Calibrating, e.g. dark current, temperature drift, noise reduction or baseline correction; Adjusting
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J1/00—Photometry, e.g. photographic exposure meter
    • G01J1/42—Photometry, e.g. photographic exposure meter using electric radiation detectors
    • G01J1/44—Electric circuits
    • G01J2001/4446—Type of detector
    • G01J2001/446—Photodiode
    • G01J2001/4466—Avalanche
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/28—Investigating the spectrum
    • G01J3/44—Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
    • G01J3/4406—Fluorescence spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N2021/0346—Capillary cells; Microcells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00—Features of devices classified in G01N21/00
    • G01N2201/06—Illumination; Optics
    • G01N2201/064—Stray light conditioning
    • G01N2201/0642—Light traps; baffles

Definitions

  • the present invention provides a device for the non-invasive monitoring and measuring of different metabolite levels in body fluids of mammals, including human.
  • the quality of the diagnosis depends on the accuracy of the measurements.
  • many laboratory methods are in use utilizing complex equipment and multi-stage pre-treatment of the test samples.
  • These kinds of analyses require trained personnel and expensive test equipment. This severely limits the number of analyses carried out which reduces the quality of the diagnosis.
  • Most often, such analyses use blood samples, which is associated with painful sampling procedures. The most common of such procedures is the continuous monitoring of blood sugar levels in patients suffering from or predisposed to diabetes.
  • Blood sugar level is one of the diagnostic markers indicative of a person’s general health.
  • the number of people suffering from blood sugar disorders is increasing every year and specifically more younger people suffering from blood sugar disorders.
  • Continuous measurement and control of the body’s response and fluctuations in blood sugar levels in response to the amount of sugar found in food is vital both at home and away to provide timely diagnostics and medical assistance for glycaemia.
  • People with diabetes are required to take blood sugar monitoring multiple times per day.
  • the main method used for express testing in domestic conditions is the measurement of blood sugar levels in capillary blood from a finger puncture. This is an invasive, and usually painful, procedure. Finger punctures are extremely inconvenient for the patient and can take several days to heal.
  • W02006/044973 discloses a device for sensing the concentration of a target analyte in a sample with a sensing element attached to an optical conduit.
  • the sensing element comprises a reporter group that undergoes a luminescence change with changing analyte concentrations.
  • US2008/0101986 describes an analytical test strip for determining different markers in bodily fluids.
  • the strip comprises a substrate layer with an electroluminescent module for generating a signal.
  • EP2989975 discloses a system for determining glucose levels comprising reference and excitation light sources.
  • the system involves the excitation of a chemical indicator, the intensity of which is related to blood glucose levels.
  • the invention also pertains to an optical measurement system comprising a fiber optic sensor with a corresponding module and system for processing the data.
  • US2013/0060107 describes a glucose sensor for detecting glucose levels in subcutaneous tissue.
  • the device measures the viability of fluorophores in the presence of various glucose concentrations.
  • a non-consumptive optical sensor is proposed for fluorescence immobilized on a substrate in hydrogel.
  • an inexpensive device employing widely-used components, such as light-emitting diodes, photodiode detectors, phase fluorometry, etc.
  • US2017/0215775 discloses a system for the continuous monitoring of glucose levels.
  • the system comprises a hand-held monitor with a display, an external transmitter, an insulin pump, and a glucose sensor.
  • the glucose sensor comprises an optical glucose sensor and an electrochemical glucose sensor.
  • US2018/0070866 discloses a device with ultra-low power consumption and a non-invasive senor system for measuring blood analytes in vivo comprising several sensors.
  • the device measures the blood hydrogen peroxide levels, pH, and/or glucose levels (as well as other analytes) in body secretions (e.g. tears, saliva, sweat).
  • the device comprises a number of chemoreceptor sensors, a microprocessor, a signal amplifier, signal filters, error correction algorithms, an analog-digital converter, and a wireless unit for transmitting electromagnetic data to a remote device for processing and/or storage (e.g. on a server or a cloud-based storage system) and/or visual presentation using software.
  • the method involves applying a sensor matrix to the skin, with the resulting electrical impulses corresponding to the glucose levels of fluids, such as tears, saliva, blood, etc.
  • US8385998 provides contact lens with integrated biosensor for the continuous, non-invasive monitoring of physiological glucose by employing biocompatible nanostructure-laden lens materials. These contact lenses can be worn by diabetics who can colorimetrically see changes in their contact lens color or other fluorescence-based properties, giving an indication of tear and blood glucose levels.
  • This invention for the glucose biosensor based on the new disposal contact lens provides a safe, convenient and non-expensive glucose sensing device.
  • the sensing device disclosed provides an efficient and non-invasive solution for monitoring blood glucose.
  • the invention is directed to an optical device comprising a contact lens having a glucose-sensing optical pattern imprinted, marked, coated or otherwise disposed on or incorporated within the contact lens.
  • the indicator pattern is further comprised of a glucose-sensing coating containing a boronic acid derivative, which reacts in the presence of glucose to create a readable pattern, which can then be correlated to a pre-determined or pre-calibrated blood glucose level.
  • the device disclosed in W02001079818 uses attenuated total reflection (ATR) infrared spectroscopy.
  • the device is used on a fingertip or another body part and compares two specific regions of a measured infrared spectrum to determine the blood glucose level of the user.
  • the device and procedure may also be used for other materials which exhibit unique mid-IR signatures of the type described herein and that are found in appropriate regions of the outer skin.
  • the invention disclosed in US6574490 relates to a quantitative near-infrared spectroscopy system, incorporating multiple subsystems in combination, providing precision and accuracy to measure analytes, such as glucose at clinically relevant levels in human tissue.
  • the invention overcomes the challenges posed by the spectral characteristics of tissue by incorporating a design which includes, in preferred embodiments, six highly optimized subsystems. [0003]
  • the persent invention provides a device with improved characteristics enabling the measurement of the levels of various markers in physiological fluids.
  • High measurement sensitivity enables the analysis of samples containing extremely low amounts of the analyzed marker.
  • the ease of use and small dimensions of the device built based on the claimed invention enable monitoring the patient’s condition at home using non-invasive physiological fluids (saliva, tears, sweat, urine). This result is achieved through the utilization of a new detection system and the position of the subsystems of the device.
  • One of the key innovations is related to a specially-designed compact photon counter, the method of positioning the photon counter in the device, and the algorithm for the operation of the device.
  • the use of the optical design described here eliminates the need for additional optical elements that would significantly contribute to measurement errors.
  • the invention disclosed herein possesses a number of advantages over the currently known devices.
  • the hand-held dimensions and ease of use of the device enable using the device of the invention as a home testing device or a portable unit for field use.
  • the positioning methods and special technical solutions used in the electronic and optical design of the device enable reducing the dimensions of the device while still retaining high sensitivity.
  • the device has no moving parts, making it resistant to mechanical influences and temperature effects.
  • the novel design of the optical subsystem eliminates strict requirements for the alignment of the sensor in relation to the emission of the beam of light (12).
  • the emission and signal detection systems are resistant to temperature effects and mechanical influences, including mechanical shocks.
  • the algorithm of operation and the design solutions employed allow achieving very low power consumption and resistance to fluctuations in supply voltage and the draining of batteries.
  • the algorithm includes automatic adjustment of the device to changes in operating conditions.
  • the high level of stability in the operation of the device ensures the high repeatability of the measurements. Deviations in repeated measurements performed using the device amount to no more than 5%.
  • the high sensitivity and broad spectrum of measured concentrations along with low measurement errors make it possible to measure extremely low concentrations of markers in various physiological fluids.
  • the device operates on the principle of excitation and registration of fluorescent radiation from a fluorescent dye bound to the marker.
  • the core technology underlying the device is presented in Fig. 1.
  • the device comprises a number of units: an optical module (101) with a chemical receptor, a sensor module (102), a data processor and controller (2), and an output module (1), e.g., a screen or a printer.
  • the optical module (101) generates the fluorescence signal which is transmitted to the sensor module (102).
  • the signal is converted into the form of an electrical signal and this information transmitted to the data processor (2).
  • Marker levels are calculated in the data processor (2) based on formulas saved in the data processor (2) and calibration.
  • the controller is combined with the data processor (2) and it monitors the operating mode of the subsystems of the device. The resulting marker levels are displayed on the display (1) or any other output device.
  • the sensor module comprises a detector device comprising Single Photon Counters (SPCs), pulse shaper (3), and tuning systems (5, 8, 7, 6, 21).
  • SPCs Single Photon Counters
  • the deviation of the geometric center of the SPC sensors from the center of the body of the device does not exceed 30 pm, eliminating the need for additional alignment and focusing of the optical system.
  • the detector is located inside a standard TO-46 package with a transparent window cap (a cylinder with a diameter of 4.7 mm and height of 4 mm).
  • SPCs Single Photon Counters
  • APD Avalanche Photodiode
  • PMT Photomultiplier Tube
  • the operation of the APD (4) and PMT (22) is based on the principle of cascading generation of an electron avalanche upon a single photon hitting the window of the sensor, creating an electric pulse at the output of the SPC sensor.
  • the electric pulse is an analog signal, which is transformed by the pulse shaper (3) into a transistor-transistor logic (TTL) pulse corresponding to the digital format consisting of a logical zero (0) or a logical one (1).
  • TTL pulse is received by the logic integration socket of the data processor (2).
  • Low logical voltage or a logical zero is registered in the absence of or at a low voltage, such as in the case of the absence of a photon.
  • the TTL pulse is transmitted to the data processor (2), where it is received as a logical signal, i.e. 0 or 1.
  • AAQS Active Avalanche Quenching System
  • AAQS (5) stops the avalanche immediately after it has been registered by the pulse shaper (3).
  • the operation of the AAQS unit (5) is initiated by the front line of the TTL pulse. Decreasing the reaction time of the APD increases the dynamic range of the photon counter (the rate of counting the number of avalanches caused by the collision of photons with the detector).
  • the APD detector (4) operates at the base voltage Vbias, which takes the diode to a state close to inducing a spontaneous avalanche. Upon hitting the detector, energetically saturated photons knock out excited electrons (by adding a portion of energy); these, in turn, knock out further electrons from the following layers of the diode.
  • the APD (4) is temperature- dependent. Optimal operating conditions are controlled by the T compensator (6) that receives temperature data from the T sensor (21 or 8) and adjusts the voltage level Vbias (7).
  • the T sensor (8) can be located on the sensor on the chip and record the temperature of the detector itself as shown in Fig. 2. At the same time, some detector designs are manufactured without internal temperature sensors or lack the possibility of installing the sensor on the chip. In such case, we foresee that the temperature sensor can be located on the body of the detector, as shown in Fig. 3.
  • the SPC unit can also employ a Photomultiplier Tube (PMT) detector (22).
  • the PMT does not require auxiliary voltage Vbias and is only weakly dependent on fluctuations in temperature. Accordingly, no Vbias (7) adjustment, temperature sensor (8, 21) or T compensator (6) is required.
  • Fig. 4 is a version of the invention utilizing PMT.
  • Power to the light source (16) is provided through the light source power driver (15), which receives activation and deactivation commands from the controller subsystem (2).
  • the light source ( 16) is a LED-type light source that goes into stable intensity illumination made a few seconds after activation.
  • the SPC (22, 4) is activated only after the light source (16) has been activated and stabilized.
  • Photon counting at the data processor (2) is commenced with the activation of the SPC. Photon registration time is established in accordance with the marker analysis method and is set by the data processor (2), e.g. 10 seconds.
  • the SPC and light source are deactivated simultaneously; upon their deactivation, the data processor stops recording signals from the SPC and initiates their processing. The sufficiency of signal statistics for calculating the concentration, as well as the optimal power consumption of the device is taken into account in establishing operating time.
  • the obtained data are processed and converted into marker concentration on the basis of calibration functions.
  • the concentration of the detected marker (C) in the physiological fluid is determined by the formula:
  • the sensor also registers the general background photon flow in the detector and has its own dark count generated by internal processes inside the sensor. These effects are persistent in character, are recorded as the base value of the sensor ( Nbase ) and taken into account in calculations of marker concentrations.
  • the difference between the number of photons recorded on the sensor ( N count ) and the base value of the sensor (Nbase) is multiplied by the calibration coefficient ( K ).
  • the calibration coefficient (K) correlates the number of photons hitting the sensor with the concentration of the marker in the analyzed volume. The coefficient is determined based on calibration tests carried out using a known concentration of the analyzed marker.
  • the result obtained is displayed on the display (1) quantitatively as the concentration of the marker per unit of volume of the sample and/or qualitatively as an indication of the level of the marker on a colored scale from green (normal) to red (dangerous).
  • the capillary (18) contains a chemical substance capable of forming complexes with the analyzed substance, also known as a chemical receptor.
  • This chemical receptor is selective for the marker and exhibits fluorophore properties only in the form of a complex with the marker. In the absence of the marker, the intensity of the fluorescence is either close to zero or the spectrum of the fluorescence is located in a band distant from the detection interval. All components of the sensor and the optical module are configured to excite and detect a specific spectrum of fluorescence corresponding to the specific marker and chemical receptor complex.
  • a specific chemical receptor is used and the subsystems of the device specifically configured for each new task.
  • the chemical receptor is loaded onto the capillary strip in a dry form.
  • a liquid sample (19) fed into the capillary (18) dissolves the chemical receptor and reacts with the receptor to form a complex.
  • the light source (16) excites the fluorescence of the complex (20), transmitting fluorescent radiation (12) to the sensor.
  • the optical module involves the excitement of the chemical receptor-marker complex and the transmission of the signal received to the sensor module with additional processing of the data.
  • Light source (16) is a LED-type light source which is selected based on the function of the device and emits a specific spectrum of light with high intensity (10).
  • the source of light (11) generates a beam of light exciting the fluorophore found in the capillary (18).
  • the LED emits photons with a wavelength of Ex in stable mode of the LED.
  • the intensity of emission is stabilized by eliminating the possibility of overheating in the LED and fluctuations in the efficiency of emission.
  • the absence of overheating problems eliminates the need for a high- power cooling system for the LED and reduces the power consumption of the entire emission module.
  • the diaphragm (40) contracts the emitted beam (10) to correspond to the dimensions of the capillary (18).
  • the sample located in the capillary is illuminated at an angle of 90° ⁇ 5° in relation to the optical axis of the sensor.
  • the diameter of the beam is determined by the dimensions of the optical channel, 1.5 mm.
  • the optical channel abuts the capillary containing the test sample.
  • the purpose of the light trap (17) is to reduce this kind of noise caused by the excitation radiation by allowing a portion (11) of the excitation radiation to pass through the capillary and then absorbing this radiation.
  • the light trap (17) may be covered in an absorbing material. A portion of the useful signal can also fall onto the light trap, but the reduction in the noise effect significantly improves the characteristics of the fluorescent beam (12).
  • the emission light passes through the collimator (41), then through a narrow-band optical filter (9) with a central wavelength of transmission equal to Em, and then to the sensor.
  • An APD (4) sensor has a small surface area which necessitates focusing the beam on the sensor.
  • the configuration with a focusing lens (42) between the filter (9) and the sensor (4) shown in Fig. 5 is used for this purpose.
  • Another variant of this configuration has the lens (42) lens installed on the filter (9) itself as shown in Fig. 6, allowing the distance between the filter and the sensor to be reduced.
  • the focused and filtered beam (14) is then directed to the APD sensor (4).
  • the use of a focusing lens is not required in the case of a PMT sensor (22), as the surface area of the sensor is bigger than the light spot.
  • Fig. 7 depicts an optical module using a PMT sensor.
  • the sample is applied to a special strip (23) connected to the capillary (18, 27).
  • the internal walls of the strip are covered in a dry form of the fluorophore.
  • the fluorophore is a special sensor substance that is maximally selective for the specific marker.
  • the fluorophore in the capillary is dissolved by the liquid test sample and reacts with the marker, which changes its spectrometric characteristics.
  • the fluorophore is excited by Ex and emits radiation at the characteristic wavelength Em. This radiation is captured by the sensor.
  • FIG. 8 A schematic diagram of the strip is shown in Fig. 8.
  • the base of the strip is made from materials efficient at absorbing photons, such as black polypropylene or polyoxymethylene (POM).
  • the main requirement for the material used for the capillary is to have a minimal level of absorption in the 350-700 nm range.
  • a round (28) or square (24) channel is cut into the strip material for affixing the capillaries (18, 27).
  • the form and dimensions of the capillary are chosen in accordance with the requirements of the method and the necessity of the calibration of the internal diameter and constant wall thickness. Calibrating the internal diameter of the capillary and the diameter of the beam Ex ensures that the volume of the analyzed solution is fixed.
  • An optical channel (25) for excitation radiation (10) from the light source and an optical channel (26) for transmitting fluorescent radiation (12) to the sensor are cut inside the strip.
  • a light trap (17) is cut out on the opposite side of the optical channel (25) to absorb excitation radiation passing through the capillary (11). This leads to a significant reduction in internal reflections of the excitation beam (10) inside the capillary and in the penetration of light into the sensor’s optical channel (12) where it would then hit the sensor.
  • Fig. 9 shows the relative size of the device placed in the palm of a person’s hand.
  • Control buttons are located on the front panel of the device: an ON/OFF button (31) for activating and deactivating the device and a START button (30) for initiating measurements.
  • the buttons can be illuminated.
  • the strip (23) is removably inserted into an opening on the side of the case.
  • the display (1) is located on the top of the case.
  • a direct method of glucose detection in a liquid requires performing a laboratory test.
  • One solution to this problem is to use a substance which can bind to glucose in order to perform a spectrometric analysis.
  • GSF Glucose Sensitive Fluorophore
  • GSF molecules selectively bind to glucose molecules, creating a stable structure. GSF forms weaker bonds with other types of sugar (such as fructose, maltose, mannose, etc.). The relative concentration of such structures is ten times smaller than in the case of glucose and, as such, does not affect the test results.
  • the complex molecule formed by GSF and glucose gains the ability to absorb photons with a specific wavelength and reemit these with another definite wavelength.
  • the individual molecules of GSF and glucose lack these qualities prior to the chemical reaction.
  • the technology is based on a special substance, fluorophore, the molecules of which selectively bind to the glucose molecule.
  • the individual molecules of GSF and glucose lack these qualities prior to the chemical reaction. In a calibrated volume of solution, the number of photons re-emitted per unit of time is strictly correlated to the number of glucose molecules found in the solution. Fluorophore synthesis
  • the obtained substance was found to be about 90% pure by HPLC analysis.
  • the substance was also analyzed by NMR and the spectra described in literature and measured in the laboratory coincided with each other down to hydrogen and carbon signals. An IR analysis was also carried out; the analysis showed the presence of all required bonds in the substance.
  • the melting point of the substance was determined to be around 225 °C during the decomposition of the product.
  • An emission spectrum scan (emission screen) was also carried out in the UV range between 380-500 nm (Fig. 10 B).
  • the resulting spectrum showed an emission band between 400 and 460 nm.
  • Significant differences in fluorescence signal intensity were also observed for the two concentrations of glucose
  • the stability of the fluorophore-GSF complex was determined in a series of experiments. No significant degradation in the signal was observed for 1 hour after the mixing of the solutions.
  • Flurophore was dissolved in 50mM phosphate buffer, pH 7.5, containing 1 0m M of NaCl. This solution was introduced into the capillary and then dried.
  • the device was configured to measure glucose in the GSF complex using the following parameters: light source (16) emission at 370 nm and filter (9) with a bandwidth of 430 ⁇ 20nm.
  • the minimum reliable measured concentration is about 5 mM with a measurement error of no more than 5%.
  • the resulting correlation between the intensity of the signal and glucose concentration in standard solutions can be used for calculating the sugar content of saliva samples.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

L'invention concerne un dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques d'un mammifère, y compris l'être humain. Le dispositif comprend un module optique comprenant une source qui émet un rayonnement électromagnétique pour exciter une substance fluorescente; un module de capteur à la sortie du module optique pour recevoir un rayonnement électromagnétique provenant du module optique; un processeur pour le traitement de données; un dispositif de commande; un affichage et une interface. La substance fluorescente est dans un capillaire, le capillaire est inséré dans une bande amovible et la bande amovible est insérée dans le module optique. Le module de capteur comprend un compteur de photons compact équipé d'un circuit de compensation thermique et d'un système d'extinction d'avalanche actif. Le module optique comprend en outre un piège à ondes électromagnétiques pour absorber un rayonnement électromagnétique superflu dans le module optique.
PCT/IB2019/054448 2019-05-29 2019-05-29 Dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques Ceased WO2020240258A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP19742649.7A EP3977097A1 (fr) 2019-05-29 2019-05-29 Dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques
PCT/IB2019/054448 WO2020240258A1 (fr) 2019-05-29 2019-05-29 Dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2019/054448 WO2020240258A1 (fr) 2019-05-29 2019-05-29 Dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques

Publications (1)

Publication Number Publication Date
WO2020240258A1 true WO2020240258A1 (fr) 2020-12-03

Family

ID=67396965

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2019/054448 Ceased WO2020240258A1 (fr) 2019-05-29 2019-05-29 Dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques

Country Status (2)

Country Link
EP (1) EP3977097A1 (fr)
WO (1) WO2020240258A1 (fr)

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4295199A (en) * 1979-10-22 1981-10-13 Bio-Rad Laboratories, Inc. Automatic fluorometer and data processor for performing fluorescent immunoassays
WO2001079818A2 (fr) 2000-04-12 2001-10-25 Medoptix, Inc. Systeme (ii) de mesure de glucose faisant intervenir la spectroscopie infrarouge par reflexion totale attenuee (atr)
US6574490B2 (en) 2001-04-11 2003-06-03 Rio Grande Medical Technologies, Inc. System for non-invasive measurement of glucose in humans
WO2006044973A1 (fr) 2004-10-19 2006-04-27 Becton Dickinson And Company Dispositif a fibres optiques pour detecter des analytes et sa methode de fabrication
US20080101986A1 (en) 2006-10-31 2008-05-01 Selwayan Saini Analytical test strip with electroluminescent module
US20120177576A1 (en) 2009-09-18 2012-07-12 Jun Jack Hu Optical device and method for non-invasive real-time testing of blood sugar levels
US8385998B2 (en) 2008-10-24 2013-02-26 Jin Zhang Contact lens integrated with a biosensor for the detection of glucose and other components in tears
US20130060107A1 (en) 2010-02-19 2013-03-07 Barry Colin Crane Subcutaneous glucose sensor
US20130084649A1 (en) * 2010-02-19 2013-04-04 Lightship Medical Limited Fluorescence measurement
EP2989975A1 (fr) 2007-02-06 2016-03-02 Medtronic MiniMed, Inc. Systèmes et procédés optiques pour la mesure ratiométrique de concentration de glucose dans le sang
US20170215775A1 (en) 2011-09-06 2017-08-03 Medtronic Minimed, Inc. Orthogonally Redundant Sensor Systems and Methods
US20180070866A1 (en) 2016-09-13 2018-03-15 Kaamran Raahemifar Non-invasive nanosensor system to determine analyte concentration in blood and/or bodily fluids.

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4295199A (en) * 1979-10-22 1981-10-13 Bio-Rad Laboratories, Inc. Automatic fluorometer and data processor for performing fluorescent immunoassays
WO2001079818A2 (fr) 2000-04-12 2001-10-25 Medoptix, Inc. Systeme (ii) de mesure de glucose faisant intervenir la spectroscopie infrarouge par reflexion totale attenuee (atr)
US6574490B2 (en) 2001-04-11 2003-06-03 Rio Grande Medical Technologies, Inc. System for non-invasive measurement of glucose in humans
WO2006044973A1 (fr) 2004-10-19 2006-04-27 Becton Dickinson And Company Dispositif a fibres optiques pour detecter des analytes et sa methode de fabrication
US20080101986A1 (en) 2006-10-31 2008-05-01 Selwayan Saini Analytical test strip with electroluminescent module
EP2989975A1 (fr) 2007-02-06 2016-03-02 Medtronic MiniMed, Inc. Systèmes et procédés optiques pour la mesure ratiométrique de concentration de glucose dans le sang
US8385998B2 (en) 2008-10-24 2013-02-26 Jin Zhang Contact lens integrated with a biosensor for the detection of glucose and other components in tears
US20120177576A1 (en) 2009-09-18 2012-07-12 Jun Jack Hu Optical device and method for non-invasive real-time testing of blood sugar levels
US20130060107A1 (en) 2010-02-19 2013-03-07 Barry Colin Crane Subcutaneous glucose sensor
US20130084649A1 (en) * 2010-02-19 2013-04-04 Lightship Medical Limited Fluorescence measurement
US20170215775A1 (en) 2011-09-06 2017-08-03 Medtronic Minimed, Inc. Orthogonally Redundant Sensor Systems and Methods
US20180070866A1 (en) 2016-09-13 2018-03-15 Kaamran Raahemifar Non-invasive nanosensor system to determine analyte concentration in blood and/or bodily fluids.

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
EGGERT, H.FREDERIKSEN, J.MORIN, C.NORRILD, J.C.: "A New Glucose-Selective Fluorescent Bisboronic Acid. First Report of Strong a-Furanose Complexation in Aqueous Solution at Physiological pH", J. ORG. CHEM., vol. 64, no. 11, 1999, pages 3846 - 3852, XP002236216, DOI: doi:10.1021/jo9819279
LI ET AL: "Immobilization enzyme fluorescence capillary analysis for determination of lactic acid", ANALYTICA CHIMICA ACTA, ELSEVIER, AMSTERDAM, NL, vol. 610, no. 2, 2 February 2008 (2008-02-02), pages 249 - 256, XP022488836, ISSN: 0003-2670, DOI: 10.1016/J.ACA.2008.01.049 *
LI Y S ET AL: "Immobilized enzymatic fluorescence capillary biosensor for determination of sulfated bile acid in urine", BIOSENSORS AND BIOELECTRONICS, ELSEVIER SCIENCE LTD. UK, AMSTERDAM, NL, vol. 24, no. 4, 1 December 2008 (2008-12-01), pages 538 - 544, XP025535115, ISSN: 0956-5663, [retrieved on 20080527], DOI: 10.1016/J.BIOS.2008.05.001 *
PROCHAZKA IVAN ET AL: "Active quenching and gating circuit of the photon counting detector for laser time transfer with improved timing resolution and stability", VISUAL COMMUNICATIONS AND IMAGE PROCESSING; 20-1-2004 - 20-1-2004; SAN JOSE,, vol. 9504, 6 May 2015 (2015-05-06), pages 950409 - 950409, XP060053140, ISBN: 978-1-62841-730-2, DOI: 10.1117/12.2178498 *
SHIJIE DENG: "Title Control circuits for avalanche photodiodes", 1 December 2013 (2013-12-01), XP055297764, Retrieved from the Internet <URL:https://cora.ucc.ie/bitstream/handle/10468/1398/thesis_Shijie.pdf?sequence=2&isAllowed=y> [retrieved on 20160825] *

Also Published As

Publication number Publication date
EP3977097A1 (fr) 2022-04-06

Similar Documents

Publication Publication Date Title
RU2655518C2 (ru) Неинвазивный анализ крови
JP6828988B2 (ja) 糖尿病管理モニタで分析物濃度を動的に較正および測定するためのシステムおよび方法
EP3458836B1 (fr) Analyse de sang non invasive
US12433513B2 (en) Device for non-invasive blood glucose concentration measurement
EP0952783A4 (fr)
US20090110603A1 (en) Method For Detecting And Compensating An Underdosage Of Test Strips
US9759714B2 (en) Methods and apparatus for normalizing path length in non-invasive glucose monitoring
EP2285267A1 (fr) Dispositif détecteur optique à spectroscopie raman améliorée
CA3145141A1 (fr) Module de capteurs pour l&#39;analyse multiparametrique d&#39;un milieu
WO2020240258A1 (fr) Dispositif compact pour la mesure non invasive de marqueurs dans des fluides physiologiques
JPH10155775A (ja) 血糖計
JP2008104751A (ja) 血糖値測定装置および血糖値測定方法
JP2008035918A (ja) 血糖値測定装置および血糖値測定方法
JP2022545163A (ja) 帯域外波長の改善された光拒絶のための光学フィルタ素子、システム及び方法
US11313799B2 (en) Calibration of a sensor
KR102854976B1 (ko) 반사 스펙트럼을 이용한 포도당 농도 측정 장치
EP2319394A1 (fr) Dispositif et procédénon invasive pour la surveillance des analytes contenus dans des échantillons biologiques
WO2025189236A1 (fr) Procédés, systèmes et dispositifs permettant de déterminer des mesures de glucose
GB2606691A (en) Non-invasive blood analysis
JP2008039428A (ja) 光学測定ユニット
HK1214112B (en) Non-invasive blood analysis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19742649

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019742649

Country of ref document: EP

Effective date: 20220103